methotrimeprazine has been researched along with Parkinson Disease, Secondary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grohmann, R; Helmchen, H; Langscheid-Schmidt, K; Müller-Oerlinghausen, B; Poser, W; Rüther, E; Scherer, J; Schmidt, LG; Strauss, A; Wolf, B | 1 |
| Bordeleau, JM; Tétreault, L | 1 |
2 other study(ies) available for methotrimeprazine and Parkinson Disease, Secondary
| Article | Year |
|---|---|
Adverse drug reactions. An epidemiological study at psychiatric hospitals.
Topics: Adult; Amitriptyline; Drug Evaluation; Female; Germany, West; Haloperidol; Hospitals, Psychiatric; Hospitals, University; Humans; Male; Mental Disorders; Methotrimeprazine; Middle Aged; Parkinson Disease, Secondary; Psychomotor Disorders; Psychotropic Drugs | 1984 |
[Study of extrapyramidal manifestations induced by neuroleptics].
Topics: Antiparkinson Agents; Chlorpromazine; Drug Synergism; Extrapyramidal Tracts; Fluphenazine; Haloperidol; Humans; Mental Disorders; Methotrimeprazine; Movement Disorders; Parkinson Disease, Secondary; Phenothiazines; Promazine; Reserpine; Tranquilizing Agents; Trifluoperazine; Trihexyphenidyl | 1972 |